Background {#Sec1}
==========

Increasing amounts of antimicrobials, including critically and highly important antibiotics for humans (CHIAH), are used for treatment of pets. There are data showing that infections in dogs and cats often are caused by resistant bacteria \[[@CR1]\]. Transmission of bacteria, particularly staphylococci, occurs between pets, owners, and veterinary staff, and the animals can act as reservoirs \[[@CR1]\]. Methicillin-resistant *Staphylococcus aureus* (MRSA) is one of the most important bacteria causing infections in mammals. Companion animals, such as cats and dogs, are seldom colonized by MRSA but they can act as a reservoir \[[@CR2]--[@CR4]\]. A recent study by Harrison et al. \[[@CR2]\] found that a population of an important, globally disseminated lineage of MRSA can infect both humans and companion animals without undergoing host adaptation. More recently numerous of MRSA lineages with a novel *mecA* gene homologue, named *mecC*, were identified. These are capable of colonizing and infecting a broad range of mammalian and avian species \[[@CR3], [@CR5]\]. In the past years, the *mecC* gene was found in other methicillin-resistant *Staphylococcus* (MRS) species as well \[[@CR6]\].

*S. pseudintermedius* is another important opportunistic pathogen of companion animals \[[@CR7]\]. This species carries different genes that encode resistance to antimicrobials \[[@CR8]\]. A study performed by Laarhoven et al. \[[@CR9]\] demonstrated that similar or indistinguishable methicillin-resistant *S. pseudintermedius* (MRSP) isolates occur in humans, contact animals and environmental samples within the same households \[[@CR9]\]. Recently MRSP clonal strains have become widely spread in Europe and North America \[[@CR8]\]. For instance, the first 13 isolates of MRSP in dogs in Sweden were reported in 2006. Since then, the occurrence of MRSP in Sweden has been reported yearly: in 2007 and 2008, more than 180 MRSP isolates were confirmed, whereas 33 isolates were detected in 2013 \[[@CR10]\]. *S. pseudintermedius* is a leading cause of skin, ear and post-operative wound infections \[[@CR11], [@CR12]\].

Another coagulase-positive *Staphylococcus* species prevalent in companion animals associated with frequent resistance to methicillin is *S. schleiferi* \[[@CR12], [@CR13]\]. Very recently, methicillin-resistant *S. schleiferi* was isolated from dogs, their owners and veterinarians \[[@CR14]\]. Coagulase-negative MRS species such as *S. epidermidis, S. haemolyticus, S. lentus, S. sciuri, and S. simulans* have been isolated from companion animals as well \[[@CR15]--[@CR17]\].

Studies on MRS prevalence in companion animals in different European countries have been reported \[[@CR7], [@CR18], [@CR19]\]. Knowledge on the occurrence of MRS in the Baltic States is sparse. The aim of this study was to investigate the occurrence of MRS species, in particular MRSA, in diseased pet animals and kennel dogs in Lithuania and to characterize the isolates according to their antimicrobial resistance, particularly to CHIAH.

Methods {#Sec2}
=======

Study design, animals and sampling {#Sec3}
----------------------------------

In 2012--2014 clinical samples were collected from 395 pet animals admitted to small animal clinics in Lithuania (Group A). Only samples sent by veterinary surgeons were included to the study. The samples were taken from diseased animals (dogs, cats, pet rabbits, guinea pigs and prairie dogs) with various clinical conditions: skin infections and wounds (*n* = 300), otitis (*n* = 45), gastrointestinal- (*n* = 25) and respiratory (*n* = 25) tract infections. Additional sampling was performed on kennels with reproductive disorders (pyometra, vaginitis, infertility, preterm birth, abortions) (Group B). Vaginal swabs from 105 bitches from 32 kennels were collected to estimate the occurrence of MRS in this subpopulation. In both studies samples were collected by a veterinary surgeon using sterile Amies media swabs (Liofilchem, Roseto, Italy) for the screening purposes. Samples were delivered to the laboratory during the same day. This study involved animals from the six counties out of 10 in Lithuania.

Bacteriological analyses {#Sec4}
------------------------

Although all clinical samples underwent diagnostic routine bacteriological culturing, the aim of this particular study was MRS screening. Therefore, swab material was inoculated onto Mannitol Salt Agar supplemented with 4 mg/L cefoxitin (Sigma-Aldrich, Hamburg, Germany country). One colony per sample was selected for further testing unless colonies were observed that differed in the fermentation of mannitol. Two colonies were taken in those cases and treated as two different isolates. Presumptive identification of staphylococci was based on the growth and morphological characteristics, catalase production, Gram-staining and susceptibility to furazolidone. Presumptive species identification was based on pigment and coagulase production, presence of protein A and clumping factor as well as on biochemical properties detected by RapID Staph Plus identification system (Thermo Scientific, Lenexa, USA). If identification reliability according manufacturer's software was less than 95 % of species probability, Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) analysis (VITEK® MS, Biomérieux, France) was used as described previously \[[@CR20]\].

Molecular analysis {#Sec5}
------------------

DNA for molecular analysis was obtained after bacterial lysis according to the extraction protocol prepared by the Community Reference Laboratory for Antimicrobial Resistance with slight modifications \[[@CR21]\]. Briefly, cultures were grown on a Mueller Hinton Agar (Liofilchem, Roseto, Italy) for 24 h and afterwards a loopful of colonies was taken from the surface of the agar and transferred to phosphate buffered saline (pH 7.3). The content was centrifuged for 5 min. The supernatant was discarded and the pellet was re-suspended in Tris-EDTA (TE) buffer. The suspension was heated using a thermomixer at 100 °C for 10 min. Boiled suspension was transferred directly on ice and diluted by 1:10 in TE.

Polymerase chain reaction (PCR) was used for the detection/confirmation of *S. aureus* and *S. pseudintermedius* using species-specific primers as described previously \[[@CR21], [@CR22]\].

Antimicrobial susceptibility testing {#Sec6}
------------------------------------

Antimicrobial susceptibility testing was performed using the broth microdilution method. Sensititre® plates and the ARIS 2X automated system (Thermo Scientific, Ashford, UK) were used with the following antimicrobials: clindamycin, erythromycin, gentamicin, tetracycline, daptomycin, ciprofloxacin, sulfamethoxazole/trimethoprim, linezolid, quinupristin/dalfopristin, vancomycin, and rifampin. Interpretation of results was carried-out using the manufacturer's software (SWIN®) adapted to clinical breakpoints of the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Strains were considered as resistant if minimum inhibitory concentrations (MIC's) of antimicrobials were \>2 mg/L for erythromycin, tetracycline and quinupristin/dalfopristin; \>0.5 mg/L for clindamycin and rifampin; \>1 mg/L for daptomycin, gentamicin and ciprofloxacin; \>4 mg/L for linezolid, sulfamethoxazole/trimethoprim and vancomycin. As there are no clinical breakpoints set for vancomycin and gentamicin to *S. pseudintermedius,* we used the breakpoints as for *S. aureus,* i.e., resistant \>2 mg/L for vancomycin and \>1 mg/L for gentamicin. The quality control strain *S. aureus* ATCC 29213 was included in each assay.

Detection of genes encoding antimicrobial resistance was performed according previously described protocols. The tested genes included *mecA* \[[@CR21]\], *mecC* \[[@CR23]\], *blaZ* \[[@CR24]\] *(beta-lactams), tet*(K), *tet*(M) \[[@CR25]\] (tetracycline), *erm*(A), *erm*(C) \[[@CR26]\], *msr*(A) (macrolides and streptogramins) \[[@CR27]\], *aac(6′)-Ie-aph(2\")-Ia and aph(3′)-IIIa* (aminoglycosides) \[[@CR27]\].

Data analysis {#Sec7}
-------------

MRS occurrence in clinical specimens and in kennel specimens were calculated by dividing the number of MRS positive specimens by the total number of investigated specimens by group (n/N, %). For percentage estimates, Wilson (Score) 95 % confidence intervals (CI 95 %) were calculated. MRS occurrence was given by animal species as well. Antimicrobial resistance rates for each tested antimicrobials were given as numbers of resistant per total number of MRS isolates. MRS occurence dependence on the kennel size (number of breeding bitches in kennel) was assessed using logistic regression analysis. Statistical analysis was performed using "IBM SPSS Statistics 20" package. Results were considered statistically significant if *P* \<0.05.

Results {#Sec8}
=======

MRS occurrence and distribution {#Sec9}
-------------------------------

### Group A {#Sec10}

Twenty-one MRS isolates were obtained from the 395 animals tested (5.3 %; CI 95 % 3.5-8.0). These included 16 dog isolates (4.6 %; CI 95 % 2.9-7.4), 4 cat isolates (10.0 %; CI 95 % 4.0-23.1) and 1 rabbit isolate (Table [1](#Tab1){ref-type="table"}).Table 1Occurrence of methicillin-resistant staphylococci (MRS) in Group A and B animalsStudyAnimal speciesNumber of animals testedNumber of MRS isolatesPercent of MRS isolatesCI 95 %Group ADogs345164.62.97.4Cats40410.04.023.1Other10110.01.840.4Total395215.33.58.0Group BDogs (bitches)1052120.013.528.6Group A consisted of 395 animalsGroup B consisted of 105 animals

All MRS isolates were resistant to oxacillin and carried *mec* genes. The *mecA* gene was present in 20 isolates whereas one isolate was positive for the *mecC* gene. This isolate was obtained from the nostril of a 6-year-old pet rabbit previously treated with antimicrobials and was identified as *S. saprophyticus* using MALDI-TOF analysis. The species of MRS isolates are presented in Table [2](#Tab2){ref-type="table"}.Table 2Distribution and susceptibility profiles of methicillin-resistant *Staphylococcus* isolates obtained from Group A pets (*n* = 21)SpeciesAntimicrobial susceptibility profile^1^ and clinical breakpoints (\>mg/L)Resistance genesNo.of isolates with this typeAnimal speciesTet (2)Ery (2)Cli (0.5)SXT (4)Cip (1)Rif (0.5)Gen (1)*S. pseudintermedius*RRRSSSS*mecA, blaZ, tetK, erm(C)*1CatRRRRSRS*mecA, blaZ, tetK, msr(A)*1CatRSSRSSS*mecA, blaZ, tetK*1CatRRRRRSS*mecA, blaZ, tetM, erm(A), msr(A)*1DogRRRSSSR*mecA, blaZ, tetK, aac(6\')*-*Ie*-*aph(2\'\')*-*Ia, aph*(*3\')*-*IIIa, erm(A)*1DogRRRRSRS*mecA, blaZ, tetK, tetM, erm(C)*1DogSRRSSSS*mecA, blaZ*1DogRRRSSSS*mecA, blaZ, tetK, erm(A)*1Dog*S. haemolyticus*RRRRSSR*mecA, blaZ, tetK, aac(6\')*-*Ie*-*aph(2\'\')*-*Ia, msr(A)*1CatSRRSRSS*mecA, blaZ, erm(A)*1DogRRRRSSS*mecA, blaZ, tetM, msr(A), erm(A)*2DogSSRSSSS*mecA, blaZ*1DogRRRSSSR*mecA, blaZ, tetK, aph(3\')*-*IIIa, erm(C*)1DogRRRSSSS*mecA, blaZ, tetM*1Dog*S. lentus*RSSSSSS*mecA, blaZ, tetK*1Dog*S. sciuri*RRRSSRS*mecA, blaZ, tetK*1Dog*S. epidermidis*RSSSSSS*mecA, blaZ, tetK*1Dog*S. equorum*SSSSSSR*mecA, aph(3\')-IIIa*1Dog*S. capitis*RSSRSSS*mecA, tetK*1Dog*S. saprophyticus*SSSSSSS*mecC, blaZ*1Pet rabbit^1^All isolates were oxacillin-resistantS -- susceptible; R -- ResistantTet -- tetracycline, Ery -- erythromycin, Cli -- clindamycin, SXT -- sulfamehoxazole/trimethoprim, Cip -- ciprofloxacin, Rif -- rifampin, Gen -- gentamicin

The most frequent location of MRS isolation was the skin (*n* = 8) including cases of pyoderma (*n* = 5) and infected wounds (*n* = 2). Four isolates were obtained from the respiratory tract; but only one animal had a severe respiratory infection (haemorrhagic pneumonia). One MRS isolate was obtained from an ear and one from an alimentary tract

### Group B {#Sec11}

Twenty-one MRS isolates were obtained from the 105 tested dogs (20.0 %; CI 95 % 3.5-8.0) (Table [1](#Tab1){ref-type="table"}). All of them carried the *mecA* gene. Logistic regression analysis revealed that increase of the kennel size by one bitch increased the odds of the occurrence of MRS by 1.125 times (95 % CI 1.041-1.215; *p* \<0.01). The highest statistically significant differences were obtained when large kennels (≥6 dogs) were compared to small kennels (≤5 dogs); odds to find MRS increased 10.1 times with increased kennel size (95 % CI 3.428--30.04; *P* \<0.001).

A wide range of MRS species was detected in both Group A and B animals (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}). *S. pseudintermedius* was the most common (8/21 and 10/21 isolates in Groups A and B, respectively). *S. haemolyticus* occurred more common in Group B (7/21) than in Group A animals (1/21). MRSA was not found at all.Table 3Distribution and susceptibility profiles of methicillin-resistant *Staphylococcus* isolates obtained from Group B dogs (*n* = 21)SpeciesAntimicrobial susceptibility profile^1^ and clinical breakpoints (\>mg/L)Resistance genesNo.of isolates with this typeKennelTet (2)Ery (2)Cli (0.5)SXT (4)Cip (1)Rif (0.5)Gen (1)*S. pseudintermedius*RRRSRSR*blaZ, tetK, aac(6\')-Ie-aph(2\'\')-Ia, aph(3\')-IIIa, msr(A)*2I, IRRRSSSR*blaZ, tetK, aph(3\')-IIIa, msr(A)*2II, IIRSSSSSS*blaZ, tetK*1IIIRSSSRSS*blaZ, tetK*1IIISRRSSSR*blaZ, aph(3\')-IIIa, ermC*1IVSRRSRRR*blaZ, aac(6\')-Ie-aph(2\'\')-Ia, aph(3\')-IIIa, msr(A)*1VSRRSRSR*blaZ, erm(A)*1VIRRRSRSR*blaZ, tetM, aph(3\')-IIIa, msr(A)*1VII*S. lentus*RSSSRSS*tetK*1IIIRRRSRSR*blaZ, tetM, aac(6\')-Ie-aph(2\'\')-Ia, erm(A)*2I, I*S. sciuri*SRRRRSR*blaZ, aac(6\')-Ie-aph(2\'\')-Ia, aph(3\')-IIIa, erm(C)*1I*S. felis*SSSSSSS*blaZ*1VIII*S. epidermidis*SSSSRSR*blaZ*1II*S. xylosus*SSSSRSS*-*1II*S. haemolyticus*RRRSRSR*blaZ, tetK, aac(6\')-Ie-aph(2\'\')-Ia, erm(C), msr(A)*1I*S. chromogenes*SRRSRSR*-*1IX*S. schleiferi*RRRSRSR*tetK, tetM, aph(3\')-IIIa, erm(C)*1I*S. capitis*SRRRSRR*blaZ, aac(6\')-Ie-aph(2\'\')-Ia*1I^1^All isolates were oxacillin-resistantS -- susceptible; R -- ResistantTet -- tetracycline, Ery -- erythromycin, Cli -- clindamycin, SXT -- sulfamehoxazole/trimethoprim, Cip -- ciprofloxacin, Rif -- rifampin, Gen -- gentamicin

Data on antimicrobial susceptibility {#Sec12}
------------------------------------

### Group A {#Sec13}

The antimicrobial susceptibility data and the genes encoding resistance in the MRS isolates are presented in Table [2](#Tab2){ref-type="table"}. All strains were susceptible to vancomycin, linezolid, daptomycin and quinupristin/dalfopristin. Three isolates demonstrated resistance to rifampin. Resistance to ciprofloxacin was infrequent as only two isolates from Group A animals were resistant. Sixteen isolates demonstrated resistance to tetracycline and carried the *tet*(K) (*n* = 9), *tet*(M) (*n* = 3) or both (*n* = 1) genes. Fourteen isolates were resistant to erythromycin and 15 to clindamycin. The isolates carried the genes *erm*(A)*, erm*(C) and *msr*(A) encoding macrolides methyltransferases and those genes were equally distributed among the isolates. Four isolates were resistant to gentamicin with attribution to the genes encoding production of (acethyl)phosphotranspherases *aac(6\'*)-*Ie*-*aph(2\'\')*-*Ia* (*n* = 2) and *aph(3′)*-*IIIa* (*n* = 3).

### Group B {#Sec14}

The data on antimicrobial susceptibility and genes encoding resistance of MRS isolated in Group B dogs are presented in Table [3](#Tab3){ref-type="table"}. Sixteen isolates were resistant to gentamicin and 15 to ciprofloxacin. Fifteen isolates were resistant to macrolides and clindamycin with highest distribution of *msr*(A) gene (*n* = 7), rather than *erm*(A) (*n* = 3) and *erm*(C) (*n* = 3).

Discussion {#Sec15}
==========

The study revealed that MRS are present in Lithuanian pet animals. The total number of positive samples/animals was 5.3 % in Group A animals and 20 % in Group B dogs, respectively. We detected 12 MRS species. The most frequently isolated species was *S. pseudintermedius*, which is known to be prevalent in dogs and cats \[[@CR7], [@CR9]\], followed by *S. haemolyticus* and *S. lentus. S. haemolyticus* is known as an important human pathogen and carrier of methicillin-resistance genes \[[@CR28]\]. Data on the occurrence of this species in dogs are still scarce. Van Duijkeren et al. \[[@CR15]\] found four isolates of methicillin-resistant *S. haemolyticus* among 11 multidrug-resistant staphylococci isolated from dogs and cats. *S. lentus* is known as a colonizer in several animal species. It has commonly been isolated from food-producing animals, including poultry \[[@CR29]\], cattle and sheep \[[@CR30]\], minks \[[@CR31]\], but is rarely associated with infections in humans \[[@CR32]--[@CR34]\]. Recently methicillin-resistant strains of *S. lentus* were isolated from dogs \[[@CR17]\]. Although we used selective medium supplemented with 4 mg/L cefoxitin, which is regarded as an appropriate medium for MRSA isolation, including low-level resistant strains \[[@CR34]\], MRSA was not found. In Lithuania, four MRSA isolates were recently isolated from pigs on a single farm, although no MRSA was found in other food-producing animal species and horses \[[@CR35]\], so MRSA occur although not detected in the investigated populations of pet animals.

Different species of MRS were obtained in this study using cefoxitin-supplemented medium, although it is suggested that oxacillin-supplemented media are more suitable for the detection of methicillin-resistance in *S. pseudintermedius* \[[@CR36]\]. Thus, the number of isolates obtained in our study is probably underestimated and may have been higher if an oxacillin-supplemented medium had been used for the initial isolation of MRS.

All isolates obtained in this study were susceptible to the latest classes of antibiotics used exclusively in humans (lipopeptides, oxazolidinones, streptogramins) as well as to vancomycin. Resistance to rifampin was detected in four MRSP isolates although this antibiotic is not used for animals in Lithuania. Resistance of MRS isolates to other CHIAH was high: 15/21 of isolates from Group B dogs were resistant toward fluoroquinolones. There are no reliable data on the use of fluoroquinolones in Lithuanian animals, but it is known that poultry products as well as products of other food producing animals species are highly contaminated with fluoroquinolone-resistant bacteria \[[@CR37], [@CR38]\]. Resistance to gentamicin was found at a high rate as well. The genes encoding resistance to aminoglycosides *aac(6′)*-*Ie*-*aph(2\")*-*Ia* and *aph(3′)*-*IIIa* were detected in this study. These genes were recently found in staphylococci isolated from companion animals in other countries, as well as in enterococci isolated from diseased cows, pigs and poultry in Lithuania \[[@CR7], [@CR39]\].

The *tet* (K) and *tet* (M) genes were found in tetracycline-resistant isolates as also found by others \[[@CR8], [@CR40]\]. *Erm* (A,C) and *msr*(A) genes encoding resistance to macrolides and clindamycin were detected with the highest prevalence of *msr*(A), particularly in the isolates from Group B dogs. Forty-one out of 42 isolates from both groups harboured the *mecA* gene, whereas *mecC* gene was detected in one *S. saprophyticus* isolate. This gene was previously found almost exclusively in MRSA isolates. To the best of our knowledge, the *mecC* gene has only been found in *S. saprophyticus* in one case previously \[[@CR41]\]. The isolate obtained by us was susceptible to all antimicrobials tested, except penicillin and oxacillin.

A high prevalence of MRS was found in Group B dogs. MRS present in the vagina may be transmitted to the environment, including surface of housewares. Moreover, breeding bitches pose a risk of transmitting MRS to their offspring, their owners and other animals.

MRS were mostly found in larger kennels (≥6 dogs) suggesting that increased population size is a risk factor for carriage of MRS.

The few *S. pseudintermedius* and *S. lentus* isolates had the same antimicrobial susceptibility profiles indicating a possible clonal spread. Isolates with similar susceptibility profiles originated from the same kennels. MRS from different kennels differ in their susceptibility profiles thus demonstrating variety among strains.

Conclusions {#Sec16}
===========

A range of MRS species were found in diseased pet animals in Lithuania with a prevalence of 5.3 %. MRSA were not found. *S. pseudintermedius* was the most common MRS species but attention should also be paid to *S. haemolyticus* and *S. lentus*. Breeding kennels, particularly keeping 6 or more female dogs were commonly infected with MRS. Staphylococci isolated from Lithuanian pets remain susceptible to antibiotics authorized exclusively for treatment of humans.
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